FI91072C - Menetelmä terapeuttisesti aktiivisten heterosyklisten peptidien valmistamiseksi ja niiden valmistuksessa käyttökelpoisia välituotteita - Google Patents

Menetelmä terapeuttisesti aktiivisten heterosyklisten peptidien valmistamiseksi ja niiden valmistuksessa käyttökelpoisia välituotteita

Info

Publication number
FI91072C
FI91072C FI882176A FI882176A FI91072C FI 91072 C FI91072 C FI 91072C FI 882176 A FI882176 A FI 882176A FI 882176 A FI882176 A FI 882176A FI 91072 C FI91072 C FI 91072C
Authority
FI
Finland
Prior art keywords
preparation
formula
peptides
therapeutically active
intermediates useful
Prior art date
Application number
FI882176A
Other languages
English (en)
Swedish (sv)
Other versions
FI91072B (fi
FI882176A0 (fi
FI882176A7 (fi
Inventor
Philip Duke Edwards
Joseph James Lewis
Charles William Perkins
Diane Amy Trainor
Richard Alan Wildonger
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878711050A external-priority patent/GB8711050D0/en
Priority claimed from GB888803206A external-priority patent/GB8803206D0/en
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of FI882176A0 publication Critical patent/FI882176A0/fi
Publication of FI882176A7 publication Critical patent/FI882176A7/fi
Publication of FI91072B publication Critical patent/FI91072B/fi
Application granted granted Critical
Publication of FI91072C publication Critical patent/FI91072C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI882176A 1987-05-11 1988-05-10 Menetelmä terapeuttisesti aktiivisten heterosyklisten peptidien valmistamiseksi ja niiden valmistuksessa käyttökelpoisia välituotteita FI91072C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8711050 1987-05-11
GB878711050A GB8711050D0 (en) 1987-05-11 1987-05-11 Selected heterocyclic ketones
GB8803206 1988-02-11
GB888803206A GB8803206D0 (en) 1988-02-11 1988-02-11 Selected heterocyclic ketones

Publications (4)

Publication Number Publication Date
FI882176A0 FI882176A0 (fi) 1988-05-10
FI882176A7 FI882176A7 (fi) 1988-11-12
FI91072B FI91072B (fi) 1994-01-31
FI91072C true FI91072C (fi) 1994-05-10

Family

ID=26292230

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882176A FI91072C (fi) 1987-05-11 1988-05-10 Menetelmä terapeuttisesti aktiivisten heterosyklisten peptidien valmistamiseksi ja niiden valmistuksessa käyttökelpoisia välituotteita

Country Status (22)

Country Link
US (1) US5164371A (fi)
EP (1) EP0291234B1 (fi)
JP (1) JPS6445395A (fi)
KR (1) KR880013926A (fi)
CN (1) CN1037519A (fi)
AT (1) ATE103293T1 (fi)
AU (1) AU605284B2 (fi)
CA (1) CA1326107C (fi)
DE (1) DE3888568T2 (fi)
DK (1) DK260588A (fi)
ES (1) ES2063034T3 (fi)
FI (1) FI91072C (fi)
GB (1) GB8809316D0 (fi)
HU (1) HU201963B (fi)
IE (1) IE62524B1 (fi)
IL (1) IL86236A (fi)
NO (1) NO176519C (fi)
NZ (1) NZ224452A (fi)
PT (1) PT87454B (fi)
SU (1) SU1678207A3 (fi)
ZA (1) ZA883006B (fi)
ZW (1) ZW4988A1 (fi)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
GB8910550D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted amides
ES2129401T3 (es) * 1990-05-24 1999-06-16 Zeneca Ltd Uso de un compuesto terapeutico para el tratamiento de bronquitis.
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
IE911697A1 (en) * 1990-05-24 1991-12-04 Zeneca Ltd Therapeutic agent
EP0475531B1 (en) * 1990-09-10 1995-01-18 Asahi Kasei Kogyo Kabushiki Kaisha Benzoic acid phenylester compounds and elastase inhibiting compositions containing the same
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US20020119985A1 (en) * 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US5556990A (en) * 1994-12-16 1996-09-17 Rhone-Poulenc Rorer Pharmaceuticals Inc. Polyarylcarbamoylaza- and -carbamoylalkanedioic acids
US5863902A (en) * 1995-01-06 1999-01-26 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
EP0977772A1 (en) 1997-04-14 2000-02-09 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6369063B1 (en) 1997-04-14 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6274602B1 (en) * 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6177572B1 (en) * 1997-08-20 2001-01-23 Sepracor, Inc. Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
US6184377B1 (en) 1997-12-15 2001-02-06 Sepracor Inc. Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
US6255453B1 (en) 1998-06-03 2001-07-03 Cortech, Inc. Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
JP2000256396A (ja) 1999-03-03 2000-09-19 Dainippon Pharmaceut Co Ltd 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤
TW200404789A (en) 1999-03-15 2004-04-01 Axys Pharm Inc Novel compounds and compositions as protease inhibitors
WO2000056724A1 (en) * 1999-03-22 2000-09-28 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Oxazole and thiazole combinatorial libraries
CA2375229A1 (en) * 1999-06-17 2000-12-28 Source Precision Medicine, Inc. Method and compounds for inhibiting activity of serine elastases
WO2002051983A2 (en) 2000-12-22 2002-07-04 Axys Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
MXPA04002282A (es) 2001-09-14 2005-03-07 Axis Pharmaceutical Inc Nuevos compuestos y preparaciones como inhibidores de la catepsina.
EP1446392A1 (en) 2001-11-14 2004-08-18 Aventis Pharmaceuticals, Inc. Oligopeptides and compositions containing them as cathepsin s inhibitors
PL371539A1 (en) * 2002-02-05 2005-06-27 Dainippon Pharmaceutical Co, Ltd. Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
CA2482207A1 (en) * 2002-04-16 2003-10-23 Axys Pharmaceuticals, Inc. Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
JP3744890B2 (ja) 2002-11-01 2006-02-15 ハッピー工業株式会社 ミシン
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
EP2019837B1 (en) * 2006-05-23 2011-03-23 Irm Llc Compounds and compositions as channel activating protease inhibitors
EP2027143A2 (en) 2006-05-23 2009-02-25 Irm Llc Compounds and compositions as channel activating protease inhibitors
MX2009005252A (es) * 2006-11-17 2009-05-28 Abbott Lab Aminopirrolidinas como antagonistas del receptor de quimiocina.
CA2677487A1 (en) 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
FR2914920B1 (fr) 2007-04-11 2011-09-09 Clariant Specialty Fine Chem F Procede de deacetalisation d'alpha-aminoacetals.
FR2916441B1 (fr) 2007-05-22 2009-08-28 Clariant Specialty Fine Chem Procede de racemisation d'alpha-aminoacetals optiquement actifs.
WO2009007415A2 (en) * 2007-07-10 2009-01-15 Probiodrug Ag Novel compounds
US20090156509A1 (en) * 2007-12-12 2009-06-18 Accuthera, Inc. Tri-peptide Inhibitors of Serine Elastases
FR2927900B1 (fr) 2008-02-27 2010-09-17 Clariant Specialty Fine Chem Procede de preparation d'alpha-aminoacetals optiquement actifs.
HRP20251570T1 (hr) * 2019-12-20 2026-01-30 Pfizer Ireland Pharmaceuticals Unlimited Company Djelotvoran postupak dobivanja derivata 6-karboksibenzoksazola

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124317B1 (en) * 1983-04-27 1990-04-11 Ici Americas Inc. Proline derivatives
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
JPH03505210A (ja) * 1988-09-09 1991-11-14 ユニバーシティー オブ ケンタッキー リサーチ ファウンデーション エラスターゼ阻害ポリマーおよび方法
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones

Also Published As

Publication number Publication date
IL86236A (en) 1994-12-29
ES2063034T3 (es) 1995-01-01
FI91072B (fi) 1994-01-31
DE3888568T2 (de) 1994-07-21
IE62524B1 (en) 1995-02-08
NO176519B (no) 1995-01-09
ATE103293T1 (de) 1994-04-15
NO882036D0 (no) 1988-05-10
IE881416L (en) 1988-11-11
AU1539088A (en) 1988-11-17
FI882176A0 (fi) 1988-05-10
EP0291234A3 (en) 1990-08-22
CN1037519A (zh) 1989-11-29
JPS6445395A (en) 1989-02-17
FI882176A7 (fi) 1988-11-12
AU605284B2 (en) 1991-01-10
EP0291234A2 (en) 1988-11-17
NO882036L (no) 1988-11-14
US5164371A (en) 1992-11-17
SU1678207A3 (ru) 1991-09-15
DE3888568D1 (de) 1994-04-28
ZW4988A1 (en) 1989-12-06
NO176519C (no) 1995-04-19
DK260588A (da) 1988-11-12
HU201963B (en) 1991-01-28
CA1326107C (en) 1994-01-11
IL86236A0 (en) 1988-11-15
PT87454B (pt) 1992-08-31
EP0291234B1 (en) 1994-03-23
GB8809316D0 (en) 1988-05-25
PT87454A (pt) 1989-05-31
KR880013926A (ko) 1988-12-22
HUT46708A (en) 1988-11-28
DK260588D0 (da) 1988-05-11
NZ224452A (en) 1991-06-25
ZA883006B (fi) 1988-11-11

Similar Documents

Publication Publication Date Title
FI882176A0 (fi) Menetelmä terapeuttisesti aktiivisten heterosyklisten peptidien valmistamiseksi ja niiden valmistuksessa käyttökelpoisia välituotteita
FI101624B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
OA09982A (fr) Derives heterocycliques leur procede de production et composition pharmaceutique les contenant
EP0368640A3 (en) Heterocyclic compounds
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
JPH07107055B1 (fi)
ATE106404T1 (de) Angiotensin-ii-antagonisten.
DK0453042T3 (da) Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner
NO173444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater
FI891279A0 (fi) Antivirala tetrahydroimidazol /1,4/ benzodiazepin-2-oner.
DK268289A (da) Cephemforbindelser og fremgangsmaade til fremstilling deraf
EP0276101A3 (en) Substituted peptide derivatives
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
ATE116974T1 (de) 5- piperazinylalkyl-1,5-benzothiazepinone verwendbar als calciumantagonisten.
PT89492A (pt) Processo de preparacao de novos derivados de tioformamida terapeuticamente activos
FI894125A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
DE68903188D1 (de) Acylsulfonamid-derivate von alpha-carbocyclyltoluylsaeuren und ihre verwendung als leukotrienantagonisten.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: ICI AMERICAS INC.

BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: ICI AMERICAS INC